Nevada Health Exchange Names New Chief Operating Officer

The Silver State Health Insurance Exchange announced today that a current staff member will become its next chief operating officer.

Damon Haycock, the exchange’s information systems project manager, will assume the role of chief operating officer on Wednesday.

Last week, Shawna DeRousse announced her resignation from that post to take a job in the private sector. DeRousse had served as the exchange’s chief operating officer since its creation three years ago.

Haycock, a UNR graduate, joined the exchange as a finance and research officer in December 2012. He was named the exchange’s information systems project manager in May.

“I am very pleased Damon has accepted the position of chief operating officer for the Silver State Health Insurance Exchange,” Bruce Gilbert, executive director of the exchange, said in a statement. “Damon did an outstanding job in managing our transition to the federal application and enrollment platform, and I am certain the exchange will benefit greatly as the result of his expanded role.”

The exchange also announced that Laura Rich will become project management officer, effective Wednesday, and will oversee case resolution as well as health plan management and certification. Rich is currently the exchange’s quality assurance officer.

Source Link

Recommended Articles

Trump Says He May Veto Extension of Health Care Subsidies

President Donald Trump said Sunday he may veto a bill to extend Obamacare subsidies if Congress sent one to his desk. Trump’s remark to reporters on Air Force Once comes after nine swing-district House Republicans joined Democrats Wednesday in advancing legislation to revive expired Affordable Care Act subsidies for three years. The Senate has yet to vote ...

Read More

Trump’s Plan To Strong-Arm Insurers Into Lower Prices Is Met With Skepticism

There are reasons to be skeptical that voluntary cuts by insurance companies could bring significant, lasting health care savings for Americans.

Read More

AbbVie To Cut Drug Prices, Pledges $100 Billion For Research

AbbVie (ABBV.N), opens new tab said on Monday that it has struck a three-year deal with U.S. President Donald Trump’s administration to reduce drug prices, and has pledged $100 billion over the next decade for research and development in the country. The drugmaker said the investment will include manufacturing and will expand direct-to-patient offerings through TrumpRx for ...

Read More

Dems Make Health Deal Offer With ACA Subsidies

Democrats sent Republicans a proposal over the weekend to renew enhanced Affordable Care Act subsidies for three years, paired with extensions of other expiring health programs, sources said. Why it matters: Sunday’s offer shows there’s increasing bipartisan sentiment to address long-stalled priorities like overhauling pharmacy benefit manager business practices — even if prospects for the ACA subsidies ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square